Egyptian scientist develops novel therapy using magnetic nanoparticles to target cancer cells
Egyptian scientist develops novel therapy using magnetic nanoparticles to target cancer cells Egypt Today
Egyptian scientist develops novel therapy using magnetic nanoparticles to target cancer cells Egypt Today
New AACR Report Cites Real Progress Against Cancer, But Also Stubborn Risks and Potential Threats University of Colorado Anschutz
FDA’s expedited IND pilot aims to shorten the timeline between drug development and first-in-human clinical trials The Cancer Letter
Local cancer advocates take message to Capitol Hill to push for funding WXXV News 25
OST-HER2-treated patients show statistically significant benefit in interim three-year OS analysis of phase IIb pulmonary metastatic osteosarcoma trial The Cancer Letter
Hawai’i cancer survivor urges Congress to make cancer research a national priority Big Island Now
AI imaging endpoint predicts OS benefit in phase III lung cancer trial: data presented at IASLC WCLC 2026 The Cancer Letter
Registrational phase II trial of arlo-cel meets primary endpoint in RRMM The Cancer Letter
“1001 CUTS,” a gynecologic oncologist’s award-winning documentary short that examines sexism in surgery, now streaming on PBS The Cancer Letter
Paula Schneider, Richard Whittington join Curebound board of directors The Cancer Letter
Texas Oncology collaborates with ACS to promote cancer screening efforts across Texas The Cancer Letter
Лечение меланомы — бесплатно: вакцина от рака кожи включена в ОМС Gorsite.ru
Что говорят эксперты о том, что онкологические больные пьют чай из листьев папайи? Vietnam.vn
First-in-Human: Jyoti Malhotra, MD, MPH on Phase I Trials, Lung Cancer in 2026, and Yale OncLive
Yorkshire Cancer Research COVID-19 Vaccination and Immunotherapy Funding Round 2026 oncodaily.com